Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema
Public ClinicalTrials.gov record NCT05608837. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety of Dexamethasone ophthaLmic Suspension Eye drOps in Uveitic and Post Surgical mAculaR eDema (The LEOPARD Study)
Study identification
- NCT ID
- NCT05608837
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Quan Dong Nguyen
- Other
- Enrollment
- 28 participants
Conditions and interventions
Interventions
- OCS-01 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 25, 2023
- Primary completion
- May 31, 2026
- Completion
- Aug 31, 2026
- Last update posted
- May 24, 2025
2023 – 2026
United States locations
- U.S. sites
- 8
- U.S. states
- 4
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retina Vitreous Associates Medical Group | Beverly Hills | California | 90211 | — |
| Retina Associates of Southern California | Huntington Beach | California | 92647 | — |
| Stein Eye Institute at UCLA | Los Angeles | California | 90095 | — |
| Byers Eye Institute at Stanford | Palo Alto | California | 94303 | — |
| Massachusetts Eye Research and Surgery Institution | Boston | Massachusetts | 02451 | — |
| Erie Retina Research | Erie | Pennsylvania | 16507 | — |
| Valley Retina Institute P.A | McAllen | Texas | 78503 | — |
| Texas Retina Associates | Plano | Texas | 75075 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05608837, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 24, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05608837 live on ClinicalTrials.gov.